Loading stock data…
Roper Technologies, Inc. (ROP)
$395.65-11.63 (-2.86%)
Market ClosedLast close Sep 8
Roper Technologies, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Roper Technologies, Inc. in the Technology sector is trading at $395.65 with a market capitalization of $41.7B. Wall Street consensus targets $445.20 (15 analysts), implying a +12.5% move over the next 12 months. The stock is currently 24% below its 52-week high of $521.28, remaining 5.6% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality. The Whystock Score of 70/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +12.5% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $2.11B↑ | $2.10B↑ | $2.06B↑ | $2.02B↑ | $1.94B |
| Gross Profit | $1.47B↑ | $1.45B↑ | $1.43B↑ | $1.40B↑ | $1.35B |
| Operating Income | $584.70M↑ | $569.60M↓ | $588.30M↑ | $573.00M↑ | $548.30M |
| Net Income | $1.17B↑ | $508.90M↑ | $428.40M↑ | $398.50M↑ | $378.30M |
Peer Comparison
AAPLMSFTGOOGL
Fundamentals
Roper Technologies, Inc. designs and develops vertical software and technology enabled products in the United States, Canada, Europe, Asia, and internationally. Its Application Software segment offers comprehensive management, diagnostic and laborato...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$41.69B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
17.57
Beta
Defensive asset. Lower volatility than the S&P 500.
0.74
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.90%
ROE
Average efficiency. Growth may require heavy reinvestment.
13.39%
Volume
Today's trading volume
585,446
Recent News
Is Roper Technologies Stock Underperforming the Dow?
Roper Technologies has notably underperformed the Dow over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Why Roche Holding (SWX:ROP) Is Getting Attention Today
Roche Holding (SWX:ROP) has been back in focus after Treeline Biosciences agreed to a clinical trial collaboration that combines TLN-121 with Roche bispecific antibodies glofitamab and mosunetuzumab for B-cell lymphomas. Roche Holding shares trade at CHF357.0, with a 90-day share price return of 10.63% and a year-to-date share price return of 9.68%. The 1-year total shareholder return of 34.18% points to momentum that has built alongside a steady stream of oncology and diagnostics...
Roche (SWX:ROP) Stock Looks Reasonable On Earnings But Mixed On Value
Roche Holding stock has delivered a solid multi year gain, yet the valuation signals are more mixed, which leaves investors weighing a strong price record against a less clear cut verdict on how cheap the shares really are. After a 3 year climb, the stock now screens as neither an obvious bargain nor clearly expensive. Roche Holding has returned about 54.2% over the past 3 years, which puts extra focus on whether that share price performance already reflects most of the good news in the...
Roche Holding (SWX:ROP) Received FDA Clearance For An Alzheimer’s Blood Test
Roche Holding (SWX:ROP) announced a collaboration with Treeline Biosciences to study combination immunotherapies for B-cell lymphomas. The partners plan to evaluate advanced immune based treatments aimed at improving options for lymphoma patients. Roche received FDA clearance for its Elecsys pTau217 blood test as the first single biomarker assay to help both rule in and rule out amyloid pathology in Alzheimer’s disease. The Elecsys pTau217 test is intended to support clinicians in earlier...
3 Dividend Stocks with Unbelievable Streaks but Barely Pay Investors
Some dividend stocks boast decades of unbroken raise streaks yet leave income investors with almost nothing to show for it. These three companies sit in that strange category, and the tension between their legendary consistency and their near-invisible payouts reveals something important about what a dividend streak actually means.